background
dihydromyricetin
dmi
import
plant
flavonoid
receiv
great
attent
due
healthbenefit
activ
includ
antioxid
antimicrobi
antiinflammatori
anticanc
antidiabet
neuroprotect
activ
dmi
capsul
sold
us
nutraceut
supplement
prevent
alcohol
hangov
major
disadvantag
associ
dmi
chemic
instabl
poor
bioavail
caus
combin
effect
low
solubl
poor
membran
permeabl
limit
practic
use
food
pharmaceut
field
scope
approach
present
paper
give
overview
current
method
identif
quantif
dmi
furthermor
recent
find
regard
main
biolog
properti
chemic
stabil
dmi
metabol
dmi
well
differ
approach
increas
dmi
bioavail
aqueou
lipid
phase
discuss
key
find
conclus
current
trend
identif
quantif
dmi
focus
spectral
chromatograph
techniqu
mani
factor
heat
ph
metal
ion
could
affect
chemic
stabil
dmi
despit
divers
biolog
effect
dmi
dmi
face
problem
poor
bioavail
util
differ
deliveri
system
includ
solid
dispers
nanocapsul
microemuslion
cyclodextrin
inclus
complex
cocrystal
phospholipid
complex
chemic
enzymat
acyl
potenti
improv
solubl
bioavail
dmi
digest
laboratori
anim
undergo
reduct
dehydroxyl
methyl
glucuronid
sulfat
novel
dmi
deliveri
system
basic
pharmacokinet
studi
encapsul
dmi
higher
anim
human
might
requir
futur
class
polyphenol
secondari
metabolit
flavonoid
frequent
found
plant
food
possess
variou
bioactiv
effect
includ
antioxid
antibacteri
antivir
antiinflammatori
anticanc
neuroprotect
activ
etc
wang
li
bi
dihydromyricetin
dmi
ampelopsin
major
bioactiv
flavonoid
isol
tradit
chines
medicin
plant
ampelopsi
grossedentata
grossedentata
zheng
liu
also
found
variou
plantbas
food
grape
red
bayberri
gadetskaya
tarawneh
zhusupova
wu
li
dmi
first
isol
ampelopsi
meliaefolia
kotak
kubota
later
report
major
bioactiv
compon
grossedentata
zhang
yang
xiong
kou
chen
content
dmi
high
ww
grossedentata
tian
zhang
yang
yang
gong
gao
lee
li
lee
major
sourc
dmi
also
includ
medic
plant
hovenia
dulci
yoo
mun
kim
chaturvedula
ruo
cedru
deodara
liang
shen
et
al
due
benefici
activ
extens
studi
dmi
structur
identif
content
determin
well
pharmacolog
effect
kou
chen
li
et
al
one
hand
number
spectral
ignat
volf
popa
chromatograph
method
ignat
et
al
naczk
shahidi
develop
analysi
quantif
dmi
hand
numer
research
effort
devot
studi
biolog
pharmacolog
activ
dmi
antioxid
antibacteri
antiinflammatori
anticanc
antiobes
neroprotect
effect
etc
kou
chen
li
et
al
nowaday
dmi
prescript
special
recommend
treatment
variou
diseas
condit
alcohol
use
disord
metabol
neuro
imbal
present
dmi
capsul
sold
unit
state
nutraceut
supplement
prevent
alcohol
hangov
dsld
major
disadvantag
associ
dmi
use
chemic
instabl
poor
bioavail
dmi
solubl
hot
water
ethanol
slightli
solubl
water
room
temperatur
mg
ml
main
caus
poor
membran
permeabl
p
eff
cm
bioavail
wang
tong
et
al
determin
factor
limit
pharmacolog
effect
clinic
applic
dmi
improv
bioavail
dmi
research
tri
use
dmi
new
drug
deliveri
system
inclus
complex
liu
et
al
ruan
yu
fu
zhu
yang
liu
liu
zhang
nanoencapsul
dalcin
et
al
microemuls
solanki
sarkar
dhanwani
cocryst
wang
tong
et
al
phospholipid
complex
liu
du
jie
chen
niu
acyl
cao
et
al
guo
zeng
lu
shu
li
et
al
li
zheng
ning
provid
higher
solubl
bioavail
addit
pharmacokinet
characterist
dmi
anim
model
human
bodi
also
vital
evalu
vivo
bioavail
efficaci
howev
partial
inform
fan
tong
dong
xiang
fan
hou
zhang
et
al
avail
basic
pharmacokinet
studi
dmi
absorpt
distribut
metabol
excret
organ
biotransform
process
metabolit
object
articl
give
overview
current
method
analysi
quantif
dmi
well
recent
find
regard
main
biolog
properti
chemic
stabil
dmi
special
attent
paid
metabol
pathway
dmi
differ
approach
carri
increas
dmi
bioavail
aqueou
lipid
phase
analysi
character
quantif
flavonoid
natur
sourc
present
challeng
mani
research
marston
hostettmann
spectral
techniqu
chromatograph
techniqu
develop
determin
dmi
plant
food
biolog
sampl
number
spectral
method
develop
quantif
total
flavonoid
dmi
complex
flavonoid
al
iii
principl
spectrophotometr
assay
use
quantif
total
flavonoid
naczk
shahidi
simpl
flavonoid
normal
maxim
absorpt
nm
owad
rubin
brenner
maxim
absorpt
dmi
observ
nm
role
c
c
doubl
bond
whose
presenc
respons
absorpt
band
ultraviolet
uv
region
biler
biedermann
valentova
kren
kubala
uv
absorpt
also
affect
natur
solvent
employ
ph
solut
high
ph
dmi
induc
format
longwavelength
peak
aris
doubl
andor
tripl
deproton
biler
et
al
moreov
possibl
interfer
uvabsorb
substanc
protein
nucleic
acid
amino
acid
anoth
spectral
method
fourier
transform
infrar
spectroscopi
ftir
use
structur
elucid
complex
flavonoid
isol
natur
resourc
jeon
chun
choi
kwon
wang
xiong
perumalla
ftir
appli
analyz
isol
compound
dmi
bark
salix
hulteni
recent
paper
report
wang
xiong
perumalla
ftir
use
quickli
distinguish
homochir
dmi
racem
dmi
extract
grossedentata
leav
physicochem
properti
two
phase
also
assess
use
ftir
nuclear
magnet
reson
nmr
spectroscopi
mass
spectrometri
ms
also
use
elucid
chemic
structur
flavonoid
standard
c
nmr
spectra
give
wealth
chemic
inform
identifi
flavonoid
ms
analysi
base
ioniz
chemic
speci
sort
ion
base
masstocharg
ratio
ignat
et
al
use
h
c
nmr
ms
puriti
steric
integr
dmi
assess
outtrup
schaumburg
madsen
recent
activ
compound
identifi
pine
needl
cedru
deodara
base
ms
nmr
data
liang
wu
qiu
zhong
gao
identif
quantif
specif
flavonoid
compound
like
dmi
perform
follow
chromatograph
techniqu
like
thinlay
chromatographi
tlc
highperform
liquid
chromatographi
hplc
highspe
counter
current
chromatographi
hsccc
highperform
counter
current
chromatographi
hpccc
tlc
rapid
simpl
method
qualit
analysi
flavonoid
plant
extract
ignat
volf
popa
pei
zhou
determin
content
dmi
grossedentala
use
tclscanner
implement
modern
standard
methodolog
led
increas
accept
recognit
dmi
hplc
anoth
prefer
method
identif
quantif
sever
flavonoid
due
simplic
sensit
hplc
condit
mainli
includ
use
revers
phase
column
binari
solvent
gradient
differ
detect
system
diod
array
detect
dad
ms
nmr
marston
hostettmann
hplc
method
success
appli
dmi
identif
quantif
healthi
food
antihangov
hepatoprotect
zou
zhou
sun
fruitstalk
extract
h
dulci
park
kim
rehman
yeputaoteng
jin
ding
zhang
red
wheat
kohyama
chono
nakagawa
hplc
also
use
analysi
dmi
content
extract
grossedentata
differ
extract
method
li
li
zhang
interest
chromatograph
altern
analysi
flavonoid
compound
includ
hsccc
du
cai
xia
gao
chen
zhou
tong
hpccc
vieira
et
al
hsccc
allliquid
chromatograph
techniqu
suitabl
prepar
isol
pure
compound
ignat
et
al
recent
hsccc
success
use
rapid
effici
separ
antioxid
includ
dmi
vine
tea
grossedentata
et
al
furthermor
purif
dmi
extract
grossedentata
leav
perform
use
triplecolumn
hsccc
solvent
system
compos
nhexaneethyl
acetatemethanolwat
vv
g
dmi
obtain
high
puriti
du
et
al
hpccc
base
supportfre
liquidliquid
centrifug
partit
chromatographi
could
appli
fast
fraction
recoveri
flavonoid
plant
extract
develop
hpccc
protocol
success
use
isol
main
flavonoid
includ
dmi
crude
extract
impatien
glandulifera
royl
vieira
winterhalt
jerz
recent
coupl
chromatograph
techniqu
ms
nmr
achiev
grow
import
structur
elucid
complex
flavonoid
compound
natur
product
biolog
sampl
use
hplctandem
electrospray
ioniz
mass
spectrometri
esim
method
major
flavonoid
extract
grossedentata
leav
tradit
solvent
extract
recrystal
identifi
dmi
gao
liu
ning
newli
establish
ultrahigh
perform
liquid
chromatographyquadrupol
mass
spectrometri
method
uhplcm
success
use
simultan
quantif
x
sorbifolia
constitu
found
wood
x
sorbifolia
rich
phenol
compound
content
dmi
mgg
zhang
recent
studi
uplcm
success
use
analysi
fruit
metabolom
dmi
actinidia
arguta
cultivar
li
fang
qi
besid
natur
product
also
report
determin
dmi
biolog
sampl
chromatograph
method
hplc
method
previous
report
determin
dmi
rat
plasma
oral
administr
decoct
grossedentata
zhang
et
al
recent
bioanalyt
method
liquid
chromatographi
lc
msm
develop
valid
quantit
dmi
rat
plasma
liu
yin
wang
tong
et
al
wu
zhang
yang
yan
liu
monitor
uptak
transport
dmi
human
intestin
cell
xiang
et
al
well
pharmacokinet
studi
dmi
organ
includ
absorpt
distribut
metabol
excret
fan
et
al
contrast
hplc
lcmsm
rapid
sensit
biolog
analysi
capillari
electrophoresi
ce
anoth
altern
analyt
tool
separ
quantif
flavonoid
base
electrophoret
migrat
charg
analyt
marston
hostettmann
techniqu
offer
high
separ
effici
resolut
power
short
analysi
time
low
consumpt
sampl
ignat
et
al
ce
techniqu
great
potenti
identif
complex
multicompon
mixtur
time
good
reproduc
sensit
naczk
shahidi
zou
zhou
sun
util
ce
simultan
determin
compon
includ
dmi
function
food
antihangov
hepatoprotect
baselin
separ
target
compon
within
min
achiev
result
shown
method
could
meet
requir
qualiti
analysi
dmi
possess
divers
biolog
pharmacolog
activ
convent
dmi
use
antioxid
antimicrobi
antivir
antiinflammatori
agent
current
research
also
shown
therapeut
benefit
treatment
variou
chronic
diseas
cancer
diabet
obes
alcohol
use
disord
metabol
neuro
imbal
kou
chen
li
et
al
reactiv
oxygen
speci
ro
includ
superoxid
anion
hydroxyl
radic
hydrogen
peroxid
h
produc
larg
amount
due
variou
reaction
go
insid
human
bodi
oxid
damag
induc
free
radic
creat
deleteri
effect
cell
tissu
may
caus
sever
biochem
problem
includ
protein
aggreg
dna
degrad
oxid
membran
lipid
park
chong
mi
flavonoid
one
power
scaveng
harm
free
radic
burda
oleszek
dmi
shown
strong
antioxid
agent
vitro
vivo
tabl
dmi
inhibit
increas
lipid
peroxid
lpo
concentr
depend
manner
linol
acid
system
zhang
ning
yang
wu
gao
liu
ning
observ
antioxid
activ
flavonoidrich
extract
dmi
grossedentata
leav
compar
tertiari
butylhydroquinon
tbhq
linol
acid
system
antioxid
activ
dmi
also
confirm
lard
oil
zhao
et
al
soybean
oil
ye
wang
duncan
eigel
okeef
sausag
wang
qin
yang
lu
qin
cook
ground
beef
ye
et
al
possibl
reason
high
antioxid
activ
due
free
hydroxyl
posit
cring
odihydroxi
system
hydroxyl
posit
bring
shown
strong
effect
free
radic
burda
oleszek
antioxid
effect
dmi
also
demonstr
variou
celltyp
assay
anim
model
dmi
exhibit
antioxid
activ
oleic
acidinduc
lipid
accumul
process
cell
due
decreas
level
cellular
triglycerid
tg
cholesterol
tc
malondialdehyd
mda
increas
superoxid
dismutas
sod
level
xie
et
al
case
human
umbil
vein
endotheli
cell
huvec
hou
et
al
cell
wang
jiao
zhou
liu
dmi
demonstr
protect
effect
h
induc
oxid
stress
similarli
dmi
protect
mous
kidney
tissu
nephrotox
attenu
cisplatininduc
oxid
stress
inflammatori
stress
moreov
dmi
increas
total
antioxid
capac
taoc
attenu
ro
gener
angii
induc
cardiac
fibroblast
neonat
spraguedawley
rat
model
meng
et
al
song
et
al
lowdens
lipoprotein
ldl
receptor
defici
mice
liu
zeng
et
al
flavonoid
may
serv
pharmacolog
accept
antimicrobi
agent
cushni
lamb
plant
flavonoid
dmi
grossedentata
liu
pang
ding
sun
cedru
deodara
zeng
sun
zhong
gao
display
strong
antibacteri
activ
gramneg
gramposit
bacteria
liu
et
al
confirm
inhibitori
effect
dmi
gramneg
food
pathogen
v
parahaemolyticu
inhibitori
effect
increas
increas
dmi
concentr
minimum
inhibitori
concentr
mic
dmi
v
parahaemolyticu
observ
mg
ml
membran
damag
assum
main
antibacteri
mechan
dmi
addit
observ
dmi
could
bind
prolin
dehydrogenas
pdh
key
regulatori
ratelimit
enzym
metabol
prolin
dmi
interact
primari
amino
acid
residu
glu
arg
gli
locat
within
activ
hydrophob
pocket
pdh
fig
lead
decreas
pdh
activ
interfer
normal
prolin
metabol
dmi
anoth
possibl
reason
v
parahaemolyticu
cell
death
ding
xiao
liu
pang
dmi
also
exhibit
antibacteri
activ
gramposit
bacteria
staphylococcu
aureu
aureu
mic
dmi
aureu
observ
mgml
dmi
chang
membran
integr
fluiditi
membran
protein
conform
also
bound
intracellular
dna
groovebind
mode
aureu
dmi
achiev
bactericid
activ
dual
effect
cell
membran
damag
dna
bind
wu
bai
zhong
huang
gao
howev
studi
huang
huang
chen
yang
huang
effect
dmi
inhibit
aureu
pria
sapria
essenti
helicas
dna
replic
restart
signific
furthermor
huang
investig
inhibitori
effect
dmi
dihydropyrimidinas
key
member
chain
pyrimidin
catabol
metabol
dna
base
pseudomona
aeruginosa
dmi
significantli
inhibit
dihydropyrimidinas
ic
valu
dmi
dock
activ
site
pocket
dihydropyrimidinas
form
stabl
complex
dihydropyrimidinas
fig
competit
inhibitor
dihydropyrimidinas
dmi
intervent
led
inhibit
bacteri
growth
promot
cell
death
medicin
flavonoid
provid
opportun
discoveri
human
immunodefici
viru
hiv
inhibitor
lower
toxic
andor
side
effect
narayan
rai
tewtrakul
dmi
prove
strong
hiv
inhibitor
absorpt
incub
acut
infect
liu
et
al
cxcchemokin
receptor
reduc
dmi
mgml
effect
dmi
partli
due
downregul
surfac
target
cell
grand
garofalo
neamati
also
confirm
major
hiv
coreceptor
promis
target
antihiv
drug
moreov
ren
song
observ
combin
use
myricitrin
dmi
shown
great
promis
resist
differ
kind
viru
hepat
b
viru
influenza
viru
andor
coronaviru
antiinflammatori
effect
flavonoid
close
link
antioxid
effect
shoham
hadziahmetov
dunaief
mydlarski
schipper
ro
exist
oxid
process
also
involv
regul
express
target
gene
relat
inflamm
nuclear
factorkgen
bind
nfkb
hoffmann
baltimor
dmi
demonstr
significantli
downregul
express
nfkb
target
gene
inhibit
inflammatori
effect
qi
et
al
tang
et
al
recent
liu
zeng
et
al
observ
dmi
prevent
hepat
aortic
inflamm
reduc
express
high
fat
dietf
ldl
receptor
defici
mice
moreov
dmi
could
also
suppress
lipopolysaccharid
lp
induc
inflammatori
cytokin
product
cell
exampl
dmi
inhibit
nitric
oxid
secret
induc
nitric
oxid
synthas
ino
product
phosphoryl
lpsstimul
macrophag
reduc
carrageenaninduc
acut
inflamm
vivo
wang
pi
et
al
flavonoid
natur
plant
demonstr
great
promis
anticanc
agent
ren
qiao
wang
zhu
zhang
cragg
kingston
newman
extens
research
conduct
anticanc
activ
dmi
vitro
vivo
studi
indic
dmi
cytotox
toward
number
human
cancer
cell
line
includ
carcinoma
breast
pancreat
lung
cancer
cell
dmi
exert
anticanc
effect
modul
multipl
signal
pathway
includ
inhibit
apoptosi
antiprolifer
metastat
inhibit
etc
fig
apoptosi
vital
process
program
cell
death
involv
cell
turnov
imbal
process
lead
abnorm
patholog
condit
includ
cancer
elmor
tumorigenesi
cancer
cell
usual
evad
apoptosi
dmi
shown
restor
promot
apoptot
mode
cell
death
mani
type
huang
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
cancer
cell
dmi
prove
promot
ro
gener
activ
mitochondriadepend
apoptosi
human
hepatocarcinoma
cell
lin
et
al
zhang
et
al
human
nonsmal
cell
lung
cancer
kao
et
al
moreov
dmi
induc
apoptosi
human
gastric
cancer
cell
ji
et
al
mous
hepatoma
cell
hepatocellular
carcinoma
cell
recent
found
dmi
induc
apoptosi
also
autophagi
cell
line
xia
et
al
human
melanoma
cell
head
neck
squamou
cell
carcinoma
dmi
induc
upregul
autophag
marker
promot
carcinoma
cell
apoptosi
control
infinit
cellular
prolifer
cellcycl
abnorm
also
potenti
therapeut
effect
cancer
treatment
collin
jack
pavletich
studi
confirm
dmi
play
import
role
regul
cancer
cell
prolifer
instanc
bladder
cancer
mediat
cell
cycl
arrest
perez
de
castro
montoya
malumbr
hepatocellular
carcinoma
cell
line
dmi
caus
cell
cycl
arrest
phase
howev
defici
fail
caus
dmyinduc
arrest
huang
hu
zhao
li
li
moreov
dmi
found
caus
cell
cycl
arrest
phage
osteosarcoma
zhao
et
al
phase
human
melanoma
cell
recent
xu
et
al
observ
dmi
produc
obviou
inhibit
prolifer
ovarian
cancer
cell
line
dose
timedepend
manner
data
indic
dmi
promis
cellcycleinterf
agent
human
cancer
cell
metastasi
lifethreaten
stage
involv
migrat
cancer
cell
origin
tissu
valastyan
weinberg
therefor
import
block
migrat
invas
tumor
cell
cancer
treatment
recent
studi
shown
dmi
could
inhibit
migrat
invas
number
human
cancer
cell
line
dmi
inhibit
express
protein
associ
prostat
cancer
result
inhibit
invas
migrat
prostat
cancer
cell
ni
gong
li
abdolmaleki
zhou
zhou
zhang
zhan
yong
observ
dmi
inhibit
invas
human
breast
cancer
cell
dosedepend
manner
downregul
express
matrix
metalloproteinas
extracellular
matrix
intracellular
space
furthermor
zhang
et
al
also
confirm
dmi
inhibit
express
mmp
key
factor
respons
migrat
invas
cell
dmi
potenti
manag
metabol
diseas
antidiabet
antiobes
shi
et
al
observ
dmi
increas
skelet
muscl
insulin
sensit
import
factor
manag
insulin
resist
type
ii
diabet
treatment
recent
liu
wan
et
al
found
dmi
retard
hyperglycemia
onset
amelior
insulin
resist
without
weight
gain
zucker
diabet
fatti
rat
dmi
also
prevent
develop
weight
gain
hyperlipidemia
atherosclerosi
apo
knockout
mous
model
william
ensor
gardner
smith
lodder
ldl
receptor
knockout
mice
liu
zeng
et
al
moreov
dmi
demonstr
increas
irisin
level
serum
new
myokin
correl
bodi
mass
index
bmi
lead
amelior
obes
diseas
furthermor
zhou
et
al
observ
dmi
administr
abrog
advers
effect
palmit
major
induc
insulin
resist
obes
dmi
may
serv
neuroprotect
neurodegen
condit
due
antioxid
defens
barnham
master
bush
dmi
found
attenu
brain
age
dgalinduc
rat
kou
et
al
dmi
also
exhibit
neuroprotect
activ
parkinson
diseas
pd
ren
zhao
cao
zhen
moreov
dmi
demonstr
protect
effect
alcohol
intox
alcohol
toler
shen
et
al
molecular
mechan
antialcohol
possibl
associ
dysfunct
gabaar
hippocampi
liang
wu
et
al
dmi
also
demonstr
protect
effect
number
diseas
injuri
blockag
melanogenesi
melanoma
cell
huang
et
al
allevi
kidney
injuri
wang
wei
qiu
liver
injuri
xie
et
al
due
antioxid
antiinflammatori
antiapoptot
activ
recent
clinic
studi
show
dmi
improv
glucos
lipid
metabol
patient
nonalcohol
fatti
liver
diseas
despit
divers
biolog
activ
plant
flavonoid
one
fundament
issu
consid
real
applic
plant
flavonoid
toxic
effect
sinc
flavonoid
regular
edibl
constitu
ordinari
food
use
tradit
medicin
examin
toxic
effect
cytotox
mutagen
genotox
carcinogen
receiv
increas
attent
elliott
middleton
kandaswami
theoharid
accord
publish
result
controversi
toxic
plant
flavonoid
one
hand
use
plant
flavonoid
regard
nontox
research
elliott
middleton
et
al
middleton
kandaswami
one
hand
plant
flavonoid
consid
act
prooxid
sahu
gray
mutagen
agent
bacteria
mammalian
test
system
dzoyem
hamamoto
ngameni
ngadjui
sekimizu
skibola
smith
toxicolog
effect
dmi
evalu
sever
studi
zhou
hu
zang
qiu
liu
assess
safeti
grossedentata
extract
teng
tea
high
level
dmi
acut
toxic
test
genet
toxic
test
feed
test
conduct
found
extract
grossedentata
toxicolog
safe
immunolog
function
enhanc
mice
furthermor
zhong
zhou
chen
zhao
et
al
studi
chronic
toxic
total
flavon
grossedentata
continu
administr
long
time
neg
effect
develop
index
hematolog
biochemistri
patholog
conclud
evalu
total
flavon
dmi
grossedentata
toxicolog
safe
moreov
xu
yao
wu
carri
acut
toxic
test
dmi
found
toxic
dmi
slight
greatest
toler
oral
gavag
rat
gkg
bodi
weight
phenol
hydroxyl
structur
dmi
make
unstabl
undergo
mani
chemic
chang
oxid
hydrolysi
ring
fission
reduct
result
metabolit
format
xiang
et
al
chemic
stabil
dmi
influenc
ph
buffer
temperatur
well
presenc
metal
ion
fe
al
cu
dmi
stabl
weak
acid
solut
unstabl
condit
basic
solut
ph
solut
stabl
ph
degrad
ruan
et
al
temperatur
also
affect
stabil
dmi
howev
studi
dealt
thermal
stabil
dmi
due
instabl
degrad
high
temperatur
chaaban
et
al
liu
li
et
al
andliu
et
al
observ
loss
dmi
water
treatment
day
lot
still
discov
impact
heat
treatment
dmi
structur
identif
degrad
product
find
essenti
biolog
activ
dmi
dmi
react
metal
ion
form
dmymet
complex
due
molecular
structur
upper
super
delocaliz
integr
conjug
larg
bond
strong
coordin
oxygen
atom
appropri
spatial
configur
li
et
al
zhang
brodbelt
wang
dmi
shown
better
biolog
activ
presenc
zn
wu
zheng
chen
co
li
yang
zhai
chen
ru
mishra
singh
trigun
singh
pandey
exist
three
potenti
coordin
site
structur
dmi
bind
metal
ion
group
c
ring
ii
ring
c
ring
group
iii
group
b
ring
samsonowicz
regulska
wu
et
al
report
metal
ion
like
bound
carbonyl
oxygen
group
c
ring
dmi
lead
increas
biolog
activ
understand
mechan
dmi
absorpt
metabol
elimin
essenti
evalu
bioavail
efficaci
level
drug
intak
manach
scalbert
morand
remesi
jimenez
howev
littl
inform
avail
dmi
absorpt
profil
distribut
metabol
excret
anim
model
human
bodi
recent
studi
xiang
et
al
human
intestin
cell
model
use
investig
uptak
transport
mechan
dmi
effect
time
concentr
ph
temperatur
efflux
transport
uptak
transport
systemat
evalu
result
show
dmi
poorli
absorb
passiv
diffus
mechan
uptak
transport
dmi
time
concentr
depend
decreas
ph
markedli
enhanc
dmi
uptak
nt
significantli
affect
bidirect
transport
dmi
poor
absorpt
blood
instabl
intestin
environ
also
observ
pharmacokinet
studi
conduct
tong
et
al
suggest
dmi
might
metabol
elimin
intestin
tract
addit
gastrointestin
stabil
dmi
vitro
investig
well
xiang
et
al
dmi
stabl
simul
gastric
fluid
buffer
solut
ph
encount
pseudofirstord
kinet
degrad
simul
intestin
fluid
buffer
solut
ph
indic
gastrointestin
ph
import
factor
strongli
influenc
stabil
absorpt
bioavail
dmi
abuhelwa
foster
upton
efflux
transport
present
human
intestin
tract
assum
anoth
factor
influenc
process
drug
absorpt
distribut
coutur
nash
turgeon
multidrug
resist
protein
breast
cancer
resist
protein
bcrp
prove
involv
uptak
transport
dmi
hinder
absorpt
dmi
intestin
tract
xiang
et
al
previou
report
reveal
transport
flavonoid
kaempferol
zheng
et
al
baicalein
kalaposkovac
et
al
also
modul
efflux
transport
cell
recent
fan
et
al
estim
tissu
distribut
excret
metabol
profil
dmi
oral
administr
rat
result
show
unconvert
dmi
could
distribut
rapidli
variou
tissu
especi
gastrointestin
tract
abl
cross
barrier
elimin
dmi
rapid
well
could
almost
complet
within
h
elimin
dmi
unconvert
found
fece
rather
urin
dmi
metabolit
detect
identifi
urin
fece
possibl
due
differ
excret
pathway
normal
metabolit
flavonoid
may
follow
pathway
excret
ie
via
biliari
urinari
rout
larg
conjug
metabolit
like
elimin
bile
wherea
small
conjug
preferenti
excret
urin
manach
et
al
rel
magnitud
urinari
biliari
excret
vari
one
flavonoid
anoth
anim
crespi
et
al
besid
metabolit
structur
metabol
pathway
also
identifi
fan
et
al
total
eight
metabolit
detect
five
metabol
pathway
consist
reduct
dehydroxyl
methyl
glucuronid
sulfat
propos
agre
previous
report
result
zhang
et
al
biolog
indic
mention
clearli
indic
potenti
dmi
natur
function
modul
problem
dmi
use
lie
poor
bioavail
low
intestin
permeabl
dmi
sparingli
solubl
water
therefor
fulli
absorb
intestin
fact
aqueou
solubl
mgml
ruan
et
al
led
absolut
bioavail
less
rat
levettrafit
gruyer
marjanov
chou
ruan
et
al
liu
yin
wang
li
better
understand
biopharmaceut
properti
dmi
would
great
help
develop
strategi
bioavail
improv
biopharmaceut
classif
system
bc
use
tool
decisionmak
formul
develop
amidon
lennerna
shah
crison
base
bc
drug
classifi
four
categori
high
solubilityhigh
cell
membran
permeabl
class
low
solubilityhigh
cell
membran
permeabl
class
ii
high
solubilitylow
cell
membran
permeabl
class
iii
low
solubilitylow
cell
membran
permeabl
class
iv
tabl
kawabata
wada
nakatani
yamada
onou
current
new
drug
candid
high
solubl
permeabl
howev
estim
market
drug
nearli
drug
development
pipelin
poorli
water
solubl
class
ii
iv
lipp
dmi
belong
bc
class
iv
requir
design
differ
formul
fig
increas
aqueou
lipid
solubl
bioavail
formul
strategi
featur
tabl
still
earli
investig
stage
enhanc
aqueou
solubl
nanoparticul
system
decreas
particl
size
lead
increas
satur
solubl
enlarg
surfac
area
wettabl
higher
dissolut
veloc
vasconcelo
sarmento
costa
solid
dispers
effect
strategi
improv
bioavail
poorli
water
solubl
drug
fig
hydrophil
polym
polyethylen
glycol
peg
polyvinylpyrrolidon
pvp
use
polymer
carrier
form
solid
dispers
ruan
et
al
increas
dmi
solubl
dissolut
rate
dmi
concentr
water
increas
function
peg
pvp
concentr
improv
solubl
might
attribut
improv
wettabl
dispers
dmi
form
intermolecular
hydrogen
bond
dmi
pvp
peg
dmi
dissolv
suspend
carrier
pvp
peg
result
realli
true
solut
leuner
dressman
solid
dispers
although
effect
improv
biopharmaceut
perform
poorli
solubl
compound
face
problem
physic
instabl
recrystal
tendenc
poor
scaleup
vasconcelo
et
al
nanoencapsul
allow
sustain
releas
encapsul
drug
maintain
plasma
concentr
therapeut
level
certain
period
time
import
control
drug
releas
frank
contri
beck
pohlmann
guterr
morahuerta
fessi
elaissari
nanocapsul
polymer
nanoparticl
compos
oili
core
surround
polymer
wall
stabil
surfact
particlewat
interfac
fig
dalcin
et
al
prepar
dmyload
nanocapsul
insert
dmi
polymer
nanoparticl
dmyload
nanocapsul
demonstr
improv
physicochem
properti
bioavail
also
effect
antimicrobi
antibiofilm
activ
urinari
cathet
infect
pseudomona
aeruginosa
dmyload
nanocapsul
reduc
biofilm
popul
urinari
cathet
h
treatment
free
dmi
elimin
furthermor
sustain
releas
dmyload
nanocapsul
observ
compar
free
dmi
howev
poor
scalabl
poor
stabil
aggreg
use
organ
solvent
major
problem
encount
nanoencapsul
microemuls
system
anoth
popular
formul
approach
solv
problem
low
bioavail
microemuls
singl
optic
isotrop
thermodynam
stabl
solut
compos
drug
oillipid
surfact
andor
cosurfact
droplet
size
submicron
rang
fig
lawrenc
ree
solanki
sarkar
dhanwani
formul
dmi
microemuls
contain
capmul
mcm
oil
phase
transcutol
p
cosurfact
cremophor
el
surfact
ratio
attain
maxim
dmi
content
dmi
microemuls
show
higher
drug
releas
compar
plain
drug
suspens
commerci
avail
tablet
due
solubilityenhanc
compon
surfact
cosurfact
despit
improv
drug
solubl
enhanc
bioavail
micromuls
effect
improv
absorpt
lower
membran
permeabl
lawrenc
ree
inclus
complex
prepar
knead
coevapor
method
exhibit
higher
dissolut
effici
correspond
physic
mixtur
xu
cyclodextrin
tabl
biopharmaceut
drug
classif
kawabata
et
al
liu
et
al
trend
food
scienc
technolog
pharmaceut
excipi
mainli
use
solubil
stabil
agent
lipophil
substanc
aqueou
prepar
astray
gonzalezbarreiro
mejuto
rialotero
suvarna
gujar
murahari
dmi
encapsul
differ
substitu
cyclodextrin
increas
solubl
dissolut
rate
fig
solubl
enhanc
dmi
form
inclus
complex
ruan
et
al
anoth
studi
liu
li
et
al
liu
et
al
dmi
complet
dispers
matrix
solubl
dmi
water
increas
mgml
stabil
antioxid
activ
dmi
greatli
enhanc
furthermor
yang
et
al
also
confirm
solubl
stabil
enhanc
dmi
water
inclus
complex
affect
progress
human
hep
cell
cycl
also
induc
cell
enter
apoptosi
recent
system
investig
inclus
complex
differ
hpcd
dmi
conduct
liu
li
nguyen
zhao
stabil
inclus
complex
form
differ
cd
follow
rank
order
mw
mw
mw
steric
effect
hydrophob
dmi
major
caus
stabil
form
inclus
complex
b
ring
dmi
like
involv
hydrogen
bond
side
group
caviti
cd
inclus
complex
stabil
although
good
solubil
stabil
agent
cyclodextrin
prone
disrupt
coupl
lower
appar
permeabl
cocrystal
new
incipi
approach
improv
solubl
permeabl
pharmaceut
product
cocryst
structur
homogen
crystallin
materi
contain
two
compon
one
compon
activ
pharmaceut
ingredi
api
compon
coform
bavishi
borkhataria
fig
cocryst
molecular
compon
held
togeth
essenti
via
nonbind
interact
hbond
van
der
waal
forc
hydrophob
interact
etc
without
alter
coval
bond
structur
api
dalpiaz
pavan
ferretti
thu
retain
pharmacolog
activ
properti
physic
properti
solubl
dissolut
rate
permeabl
stabil
compact
behavior
improv
cocrystal
process
wang
tong
et
al
prepar
two
novel
solubl
cocryst
dmi
caffein
urea
evalu
physicochem
properti
maximum
solut
concentr
reach
within
min
two
cocryst
mgml
dmycaffein
dmyurea
respect
cocryst
powder
could
gener
solut
higher
concentr
dmi
maintain
degre
supersatur
least
day
enhanc
solubl
dmi
cocryst
achiev
mainli
due
decreas
lattic
energi
increas
solvent
affin
cocrystal
process
face
problem
complex
prepar
prematur
precipit
poorli
solubl
drug
techniqu
complex
bioactiv
molecul
dietari
phospholipid
develop
improv
bioavail
plant
extractsact
poor
absorpt
alexand
ajazuddin
patel
saraf
saraf
hu
liu
zhang
zeng
phospholipid
act
amphipath
molecul
show
consider
solubl
aqueou
lipid
media
fig
besid
phospholipid
one
major
compon
cell
membran
facil
permeat
drug
across
lipidrich
membran
without
disturb
cellular
lipid
bilay
henc
increas
bioavail
khan
alexand
ajazuddin
saraf
saraf
zhang
et
al
liu
du
jie
chen
niu
develop
dmylecithin
complex
order
improv
hydrophob
dmyth
solubl
dmi
noctanol
rose
mgml
lipophil
properti
dmi
significantli
improv
due
dmi
combin
lecithin
noncoval
bond
furthermor
antioxid
perform
dmi
improv
complex
lecithin
phospholipid
complex
may
consid
promis
drug
deliveri
system
improv
overal
absorpt
bioavail
plant
flavonoid
howev
low
stabil
acid
ph
high
cost
raw
materi
limit
applic
order
increas
solubl
stabil
dmi
fatti
phase
acyl
dmi
fig
make
hydrophob
fatti
acid
linkag
report
sever
studi
guo
et
al
li
zheng
ning
matsumoto
tahara
li
et
al
esterifi
dmi
lauroyl
chlorid
antioxid
activ
obtain
product
dmylaur
lard
oil
superior
dmi
furthermor
solubl
antioxid
activ
synthes
singleand
multiacyl
dmi
peanut
oil
phase
increas
compar
dmi
guo
et
al
howev
chemic
acyl
regioselect
lead
unwant
function
phenol
hydroxyl
group
contrari
enzymat
acyl
dmi
gain
increas
attent
due
high
effici
green
process
mild
reaction
condit
high
regioselect
instanc
enzymat
acyl
dmi
achiev
sever
lipas
fast
reaction
rate
high
convers
yield
furthermor
deng
et
al
design
polydopamineco
magnet
iron
oxid
nanoparticl
pdmnp
immobil
aspergillu
niger
lipas
anl
increas
stabil
reusabl
catalyt
perform
lipas
anl
pdmnp
appli
biocatalyst
regioselect
acyl
dmi
dmso
gave
convers
higher
previou
report
recent
cao
et
al
use
novel
deep
eutect
solvent
de
cosolv
system
reaction
medium
enzymat
acyl
dmi
catalyz
anl
pdmnp
convers
dmi
lipidsolubl
time
higher
dmi
lipasecatalyz
deriv
exhibit
rel
strong
radic
scaveng
abil
dmi
bioactiv
flavonoid
present
plant
variou
plantbas
food
grape
red
bayberri
convent
innov
method
includ
spectral
chromatograph
method
report
identif
quantif
dmi
natur
sourc
biolog
sampl
numer
studi
report
divers
pharmacolog
activ
dmi
includ
antioxid
antimicrobi
antiinflammatori
anticanc
antidiabet
neuroprotect
effect
etc
indic
dmi
potenti
use
nutrit
supplement
treatment
variou
diseas
phenol
hydroxyl
group
dmi
make
chemic
unstabl
oxid
report
main
caus
chang
dmi
avoid
metal
ion
high
temperatur
alkalin
condit
process
storag
import
minim
degrad
dmi
dmi
also
face
problem
poor
bioavail
limit
pharmacolog
effect
clinic
applic
overcom
barrier
research
tri
use
differ
strategi
enhanc
dmi
solubl
bioavail
aqueou
lipid
phase
formul
base
solid
dispers
nanocapsul
microemuslion
cyclodextrin
inclus
complex
cocrystal
phospholipid
complex
chemic
enzymat
acyl
propos
increas
lipid
solubl
understand
mechan
dmi
absorpt
metabol
elimin
essenti
evalu
vivo
bioavail
efficaci
dmi
digest
laboratori
anim
undergo
reduct
dehydroxyl
methyl
glucuronid
sulfat
basi
current
review
futur
research
need
dmi
focu
follow
three
aspect
develop
new
deliveri
system
dmi
obtain
higher
encapsul
overal
absorpt
bioavail
effici
ii
pharmacokinet
studi
encapsul
dmi
absorpt
distribut
metabol
excret
vivo
set
higher
anim
human
iii
transform
encapsul
dmi
safe
product
provid
health
benefit
consum
